Product Information

INVEGA SUSTENNA 117 MG/0.75 ML is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $2337.4796 per ML under NDC 50458056201. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Jul 31, 2009.

INVEGA SUSTENNA 117 MG/0.75 ML

paliperidone palmitate
$2337.4796per ML

Strength

117 mg/.75mL

NDC

50458056201

Classification

Brand

Dosage Form

INJECTION

Route

INTRAMUSCULAR

Effective Date

11/18/2026

Active Ingredients

PALIPERIDONE PALMITATE

Approval Type

New Drug (NDA)

FDA Application

NDA022264

FDA Approved

7/31/2009

On Market Since

7/31/2009

Pharmacological Classes

Price Statistics

The NADAC for INVEGA SUSTENNA 117 MG/0.75 ML has been published 678 times since Nov 28, 2013, and over the history we have for it it has risen 104.6%. The table below summarizes its recorded NADAC range and movement.

Current price$2337.4796 per ML
All-time high$2344.7659 (Jun 10, 2026)
All-time low$1142.5583 (Nov 28, 2013)
52-week high$2344.7659
52-week low$2283.2261
Median price$1797.5591
Average price$1784.5060
Largest weekly change+6.9% (Jan 16, 2019)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

-0.0%

1M

-0.1%

3M

-0.1%

6M

-0.3%

1Y

+2.4%

3Y

+8.9%

5Y

+24.0%

All

+104.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the paliperidone palmitate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of INVEGA SUSTENNA 117 MG/0.75 ML?

The current National Average Drug Acquisition Cost (NADAC) for INVEGA SUSTENNA 117 MG/0.75 ML, manufactured by Janssen Pharmaceuticals Inc., is $2337.4796 per ML (NDC 50458056201), effective Nov 18, 2026.

How has the price of INVEGA SUSTENNA 117 MG/0.75 ML changed over time?

Over the history we have for it, the NADAC for INVEGA SUSTENNA 117 MG/0.75 ML has risen 104.6%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for INVEGA SUSTENNA 117 MG/0.75 ML?

Since Nov 28, 2013, the NADAC for INVEGA SUSTENNA 117 MG/0.75 ML has ranged from a low of $1142.5583 (Nov 28, 2013) to a high of $2344.7659 (Jun 10, 2026), with a median of $1797.5591 per ML.

Are there cheaper alternatives to INVEGA SUSTENNA 117 MG/0.75 ML?

No other NADAC-published product currently shares the active ingredient and strength of INVEGA SUSTENNA 117 MG/0.75 ML in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures INVEGA SUSTENNA 117 MG/0.75 ML?

INVEGA SUSTENNA 117 MG/0.75 ML (NDC 50458056201) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.